1,2-dipalmitoylphosphatidylcholine has been researched along with Staphylococcal Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, O; Cordfunke, RA; de Boer, L; de Breij, A; Drijfhout, JW; Emanuel, N; Kwakman, PH; Moriarty, TF; Nibbering, PH; Riool, M; Zaat, SA | 1 |
| Ding, J; Li, J; Shi, J; Xu, YQ; Zhu, CT | 1 |
2 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Staphylococcal Infections
| Article | Year |
|---|---|
Prevention of Staphylococcus aureus biomaterial-associated infections using a polymer-lipid coating containing the antimicrobial peptide OP-145.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Biofilms; Cholesterol; Female; Lactic Acid; Mice, Inbred C57BL; Nail Diseases; Phosphatidylcholines; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostheses and Implants; Rabbits; Silicones; Staphylococcal Infections; Staphylococcus aureus | 2016 |
Liposome combined porous beta-TCP scaffold: preparation, characterization, and anti-biofilm activity.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Anti-Bacterial Agents; Biofilms; Calcium Phosphates; Cholesterol; Delayed-Action Preparations; Diffusion; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Gentamicins; Kinetics; Liposomes; Models, Chemical; Osteomyelitis; Particle Size; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Tissue Scaffolds | 2010 |